buserelin has been researched along with Experimental Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Teplán, I | 1 |
| Coyle, J; Fisher, B; Gunduz, N; Rudock, C; Saffer, E | 2 |
1 review(s) available for buserelin and Experimental Neoplasms
| Article | Year |
|---|---|
Peptides and antitumor activity. Development and investigation of some peptides with antitumor activity.
Topics: Animals; Antineoplastic Agents, Hormonal; Buserelin; Gonadotropin-Releasing Hormone; Mammary Neoplasms, Animal; Neoplasms, Experimental; Oligopeptides; Somatostatin | 2000 |
2 other study(ies) available for buserelin and Experimental Neoplasms
| Article | Year |
|---|---|
Serum growth factor following primary tumor removal and the inhibition of its production by preoperative therapy.
Topics: Animals; Buserelin; Combined Modality Therapy; Culture Media; Cyclophosphamide; Female; Goserelin; Growth Substances; In Vitro Techniques; Mice; Neoplasms, Experimental; Preoperative Care; Tamoxifen; Tritium | 1990 |
Effect of local or systemic treatment prior to primary tumor removal on the production and response to a serum growth-stimulating factor in mice.
Topics: Animals; Buserelin; Combined Modality Therapy; Cyclophosphamide; DNA; Female; Goserelin; Growth Substances; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Tamoxifen | 1989 |